Analystreport

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.

Spectrum Pharmaceuticals, Inc.  (SPPI) 
Last spectrum pharmaceuticals, inc. earnings: 2/27 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.sppirx.com/investor-relations